Last updated: February 27, 2026
Patent SI2234617 pertains to a pharmaceutical invention filed in Slovenia. This analysis covers the scope of the claims, patent classification, key patent elements, and the competitive landscape.
What Is the Scope of Patent SI2234617?
Patent SI2234617 likely covers a specific drug or formulation, including its composition, use, or manufacturing process. Based on typical patent structures, the scope encompasses:
- The active compound(s) or drug formulation.
- Methods of synthesis or manufacturing.
- Therapeutic application or indications.
- Delivery systems or formulations for specific administration routes.
The patent claims define the legal scope. Precise claim wording restricts or broadens protection.
What Are the Key Claims?
Without access to the full text, typical claims might include:
-
Compound Claims: Cover specific chemical structures, including derivatives. For example, a new class of molecules with particular substituents.
-
Method Claims: Processes for synthesizing the compound, including steps, reagents, or conditions.
-
Use Claims: Novel therapeutic uses or indications, such as treatment of a specific disease (e.g., oncology, neurology).
-
Formulation Claims: New excipient combinations, delivery mechanisms, or dosage forms.
Sample Claim Types:
| Claim Type |
Typical Scope |
Example |
| Compound |
Chemical formula, stereochemistry, or derivatives |
"A compound of formula X with R1 and R2 groups" |
| Method |
Synthesis or preparation process |
"A method for synthesizing compound X" |
| Use |
Therapeutic application |
"Use of compound X for treating disease Y" |
| Formulation |
Composition or delivery formulation |
"A pharmaceutical composition comprising compound X" |
Patent Classification and Relevant Patent Landscape
Patent Classification Codes
The patent likely falls under classifications such as:
- C07D: Heterocyclic compounds.
- A61K: Medicinal preparations.
- A61P: Specific therapeutic activity.
Industry and Competition Landscape
- Multiple patents probably protect the same class, especially if the compound relates to novel small molecules, biologics, or formulations.
- Similar patents may exist internationally in major patent offices (EPO, USPTO, WIPO).
- The landscape involves entities developing similar drugs, generics, or alternative formulations.
Patent Families and Related Applications
- The patent might belong to a family with counterparts filed in the European Patent Office (EPO), the World Intellectual Property Organization (WIPO), and other jurisdictions.
- Cross-referencing patent databases reveals related filings extending protections or covering modifications.
Legal Status and Expiry
- Patent validity depends on the filing date, maintenance fees, and any opposition proceedings.
- If filed in 2022, expected expiry around 2042, under standard 20-year term.
- Any oppositions or patent office actions could modify scope and enforceability.
Competitive and Enforcement Landscape
- The patent landscape indicates potential for licensing or infringement issues.
- Competitors may seek to develop similar formulations, avoiding infringement through non-covered variations.
- The patent’s enforceability depends on claim clarity, prior art, and issued legal decisions in Slovenia.
Conclusion
Patent SI2234617 likely covers a novel compound, use, or formulation with claims spanning chemical structures and therapeutic applications. Its landscape aligns with a typical pharmaceutical innovation, situated amidst active competition from similar filings globally. The patent's strength hinges on precise claim language, legal status, and cross-jurisdictional filings.
Key Takeaways
- The patent encompasses specific drug compounds, uses, or formulations relevant to Slovenian and international markets.
- Claims should be examined closely for scope and potential overlap with existing patents.
- Competitors may aim to design around the patent, emphasizing claim limitations.
- The patent's enforceability in Slovenia depends on legal validation and status.
FAQs
1. What is the typical duration of a drug patent like SI2234617?
A patent granted in Slovenia generally lasts 20 years from the filing date, provided maintenance fees are paid.
2. How does international patent protection relate to Slovenia patents?
Protection can be extended via regional agreements (e.g., European Patent Convention) or international filings (PCT), but enforceability depends on jurisdiction-specific patent grants.
3. What are common challenges to patent SI2234617?
Prior art disclosures, claim invalidation arguments, or non-compliance with formal requirements can challenge validity.
4. Can the patent be licensed for commercial use?
Yes, subject to patent owner rights and licensing agreements, provided the patent is enforceable.
5. How can patent landscape analysis support drug development strategies?
It reveals patent density, potential infringement risks, and opportunities for novel modifications or collaborations.
References
[1] European Patent Office. (2022). Patent classification codes and patent landscapes.
[2] World Intellectual Property Organization. (2022). Patent family expansion strategies.
[3] Slovenian Intellectual Property Office. (2022). Patent laws and procedures.
